Jim Cramer's Lightning Round: Nokia, Voyager Technologies, Dentsply, and Immunome Stock Picks

Lightning Round Stock Analysis

• 🚀 Voyager Technologies is considered a very good speculation due to its involvement in space and national security sectors.
• 💡 Immunome, a clinical-stage biotech company, is noted for developing targeted cancer therapies but is also losing significant money, making it a speculative play rather than an investment.

Nokia's Competitive Landscape

• ⚠️ Nokia faces tough competition from major players like Apple and other strong companies in its industry.
• 🍎 Despite Nokia's challenges, Cramer suggests that Apple, which was down that day, presents a good buying opportunity at its current price level.

Dentsply Stock Outlook

• 📈 Dentsply (ticker XRAY) is identified as a company that was once expensive but is now worth very little, suggesting it represents some value.
• 💰 Cramer recommends buying some Dentsply and putting it away, indicating a positive outlook for its future.

Market Pessimism vs. Reality

• 📊 The segment touches on how market pessimists were wrong about tariff policies potentially ruining the market in 2025, as gains were seen across the board.
• 🧐 Cramer plans to dive deeper into why these pessimists were incorrect in their predictions.